2021 American Transplant Congress
Renal Tubular-cell-specific Urinary Extracellular Vesicles: A Novel Biomarker for Diabetic Nephropathy After Kidney Transplantation
*Purpose: Diabetes(DM) is a leading cause of ESRD among renal transplant recipients(RTRs). However, the kinetics of diabetic nephropathy recurrence after renal transplantation(RT) remains unclear. Currently,…2021 American Transplant Congress
Clinical Effect of Post-transplant Av-fistula Ligation on Hemodynamic Status and Kidney Allograft Function
Nephrology, Indiana University, Indianapolis, IN
*Purpose: Ligation of AVF post kidney transplant often done mostly for esthetic reasons, however, they are occasionally indicated in the presence severe steal syndrome, severe…2021 American Transplant Congress
The Association of Pre-Kidney Transplant C-Peptide Level with Post Transplant Outcomes
Nova Scotia Health Authority Division of Nephrology, Departm, Halifax, NS, Canada
*Purpose: Insulin is produced by pancreatic beta-cells by cleavage of a prohormone precursor into equal parts insulin and C-peptide. C-peptide has been shown to have…2021 American Transplant Congress
Donor Derived Cell Free Dna: Teasing Out the Optimal Threshold for Antibody Mediated Rejection
*Purpose: Donor-derived cell-free DNA (dd-cfDNA) assay is a putative noninvasive marker for renal allograft rejection and other etiologies of injury such as BK nephropathy. The…2021 American Transplant Congress
The Summarized Assessment of Endothelin a Receptors Expression in Renal Transplant Compartments is Associated with Antibody Mediated Rejection
*Purpose: The presence of non-HLA anti-endothelin A receptor antibodies may be important in transplant injury but the expression of the endothelin A receptor (ETA receptor)…2021 American Transplant Congress
Risk Factors and Outcome of Transplant Renal Artery Stenosis in Kidney Transplant Recipients – A Nested Case-control Study
*Purpose: Transplant renal artery stenosis (TRAS) is a treatable cause of renal allograft dysfunction. It presents commonly in the early post-transplant period with variable clinical…2021 American Transplant Congress
Transplant Center Volume in High-risk Recipient Association with Graft and Patient Survival
Transplant, Washington University, Saint Louis, MO
*Purpose: Evaluation of high-risk recipients in transplant centers involves an intensive multidisciplinary medical evaluation and requires extensive coordination amongst various teams to follow-up on these…2021 American Transplant Congress
Combined Liver-Kidney Transplantation in Adults With End-Stage Liver Disease: Risk Factors in Patients with Chronic Kidney Disease Stages 3-5, Not on Maintenance Dialysis
University of Florida, Gainesville, FL
*Purpose: We aimed to identify the risk factors for combined liver-kidney transplantation (CLKT) vs. liver transplantation alone (LTA) in end stage liver disease (ESLD) patients…2020 American Transplant Congress
Clinical Implication of Tertially Lymphoid Tissue in the Renal Graft
*Purpose: Tertialy lymphoid organs (TLTs) are defined as inducible lymphoid tissues that arise in non-lymphoid organs, and chronic sustained inflammation is one of the most…2020 American Transplant Congress
Evaluation of Apixaban Usage in Solid Organ Transplant Patients with Renal Impairment
Pharmacy, CHI St. Luke's Health-Baylor St. Luke's Medical Center, Houston, TX
*Purpose: There remains a gap in the literature for apixaban dosing recommendations for treatment of deep vein thrombosis (DVT) or pulmonary embolism (PE) in special…
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 17
- Next Page »